Raymond James & Associates’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$148K Buy
21,515
+1,304
+6% +$7.69K ﹤0.01% 3718
2024
Q2
$150K Buy
20,211
+142
+0.7% +$998 ﹤0.01% 3667
2024
Q1
$147K Buy
20,069
+4,256
+27% +$36.4K ﹤0.01% 3682
2023
Q4
$98K Buy
+15,813
New +$70.9K ﹤0.01% 3646

Other funds holding ARDX

Raymond James & Associates's ARDX Position: Q3 2024 in Review

Raymond James & Associates increased its Ardelyx (ARDX) stake by 6.5% in Q3 2024, buying an estimated $7.69K and bringing the position to 21,515 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3718.

Raymond James & Associates first reported a position in ARDX in Q4 2023 and has held it in 4 quarters since. The position peaked at $150K in Q2 2024. 203 funds tracked by Wall St. Rank hold ARDX as of Q3 2024.

  • Raymond James & Associates held 21,515 shares of Ardelyx worth $148K as of Q3 2024.
  • Raymond James & Associates bought 1,304 Ardelyx shares in Q3 2024, an estimated $7.69K.
  • Ardelyx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3718 holding.
  • Raymond James & Associates first reported a position in Ardelyx in Q4 2023 and has held it in 4 quarters since.
  • Raymond James & Associates's Ardelyx position peaked at $150K in Q2 2024.
  • 203 funds tracked by Wall St. Rank held Ardelyx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.